Theratechnologies Inc - Strategic SWOT Analysis Review
Description
Theratechnologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Theratechnologies Inc (Theratechnologies) is a biopharmaceutical company that focuses on the discovery and development of drugs for people with orphan medical conditions. The company’s marketed products include Egrifta SV, which is indicated to reduce excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a CD-4 directed post-attachment HIV-1 inhibitor indicated for HIV type 1 infection in the US. Its pipeline products include Trogarzo IV slow push for HIV and Egrifta F8 for NASH HIV. The company is also developing TH 1902 for triple-negative breast cancer and TH1904 for ovarian cancer. It develops products based on peptide stabilisation technology to increase target protein resistance to enzymatic degradation. Theratechnologies is headquartered in Montreal, Quebec, Canada.
Theratechnologies Inc Key Recent Developments
Jul 03,2025: Theratechnologies to Announce Second Quarter 2025 Financial Results
Apr 09,2025: Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
Apr 03,2025: Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
Mar 12,2025: Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People With HIV
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Theratechnologies Inc (Theratechnologies) is a biopharmaceutical company that focuses on the discovery and development of drugs for people with orphan medical conditions. The company’s marketed products include Egrifta SV, which is indicated to reduce excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a CD-4 directed post-attachment HIV-1 inhibitor indicated for HIV type 1 infection in the US. Its pipeline products include Trogarzo IV slow push for HIV and Egrifta F8 for NASH HIV. The company is also developing TH 1902 for triple-negative breast cancer and TH1904 for ovarian cancer. It develops products based on peptide stabilisation technology to increase target protein resistance to enzymatic degradation. Theratechnologies is headquartered in Montreal, Quebec, Canada.
Theratechnologies Inc Key Recent Developments
Jul 03,2025: Theratechnologies to Announce Second Quarter 2025 Financial Results
Apr 09,2025: Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
Apr 03,2025: Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
Mar 12,2025: Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People With HIV
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
51 Pages
- Section 1 - About the Company
- Theratechnologies Inc - Key Facts
- Theratechnologies Inc - Key Employees
- Theratechnologies Inc - Key Employee Biographies
- Theratechnologies Inc - Major Products and Services
- Theratechnologies Inc - History
- Theratechnologies Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Theratechnologies Inc - Business Description
- Product Category: Egrifta SV
- Performance
- Product Category: Trogarzo
- Performance
- Geographical Segment: Europe
- Performance
- Geographical Segment: USA
- Performance
- R&D Overview
- Theratechnologies Inc - Corporate Strategy
- Theratechnologies Inc - SWOT Analysis
- SWOT Analysis - Overview
- Theratechnologies Inc - Strengths
- Theratechnologies Inc - Weaknesses
- Theratechnologies Inc - Opportunities
- Theratechnologies Inc - Threats
- Theratechnologies Inc - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Theratechnologies Inc, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Jul 03, 2025: Theratechnologies to Announce Second Quarter 2025 Financial Results
- Apr 09, 2025: Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
- Apr 03, 2025: Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
- Mar 12, 2025: Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People With HIV
- Feb 26, 2025: Theratechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
- Feb 26, 2025: Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
- Feb 14, 2025: Theratechnologies to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Business Update
- Feb 14, 2025: Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
- Jan 10, 2025: World Orphan Drug Alliance Expands to Canada and Full Latam Region, Completing the First Truly Global Commercialization Offering
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Theratechnologies Inc, Key Facts
- Theratechnologies Inc, Key Employees
- Theratechnologies Inc, Key Employee Biographies
- Theratechnologies Inc, Major Products and Services
- Theratechnologies Inc, History
- Theratechnologies Inc, Other Locations
- Theratechnologies Inc, Subsidiaries
- Theratechnologies Inc, Key Competitors
- Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Theratechnologies Inc, Recent Deals Summary
- List of Figures
- Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
